Trials / Terminated
TerminatedNCT02371031
FDOPA-PET/MRI for the Pre-operative Evaluation of Gliomas
- Status
- Terminated
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Washington University School of Medicine · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a pilot study designed to evaluate the potential of using FDOPA-PET/MRI for improving surgical planning and providing non-invasive prognostic information in patients with gliomas that have substantial non-enhancing regions. The results will be used to develop larger adequately powered studies.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | 6-[F-18]-Fluoro-L-3,4,-dihydroxyphenylalanine | |
| DEVICE | PET/MRI | |
| PROCEDURE | Surgical resection (standard of care) |
Timeline
- Start date
- 2015-03-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2015-02-25
- Last updated
- 2016-11-30
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02371031. Inclusion in this directory is not an endorsement.